Metraipolis › archive › dc_beb67abfc4de
Immune-mediated gastritis in a patient with breast cancer due to therapy with immune checkpoint inhibitor pembrolizumab: a case report — Europe PMC PMID:41142620
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41142620
- DOI
- 10.3389/fonc.2025.1624185
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:16:29.377Z
- SHA-256 of the archived text
668b28a41dea49f7b877880ce20f1de91a5a874f9c1c57f21830322f238ba4af- Stable URL of this page
https://metraipolis.com/documento/dc_beb67abfc4de
How to cite
Immune-mediated gastritis in a patient with breast cancer due to therapy with immune checkpoint inhibitor pembrolizumab: a case report — Europe PMC PMID:41142620 — Europe PMC (en), https://europepmc.org/article/MED/41142620 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb67abfc4de (Metraipolis archive dc_beb67abfc4de, sha256 668b28a41dea49f7b877880ce20f1de91a5a874f9c1c57f21830322f238ba4af)
BibTeX
@misc{dcbeb67abfc4de,
title = {Immune-mediated gastritis in a patient with breast cancer due to therapy with immune checkpoint inhibitor pembrolizumab: a case report — Europe PMC PMID:41142620},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41142620},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb67abfc4de; sha256 668b28a41dea49f7b877880ce20f1de91a5a874f9c1c57f21830322f238ba4af},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142620. Agents can read the archived copy with the MCP tool read_document.